Zentiva Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Private

  • Employees
  • 4,800

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 10

  • Investments
  • 7

Zentiva General Information

Description

Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25 European markets. The company therapeutic areas inlcude Cardiovascular, Central nervous system, Gastrointestinal and metabolic disorders, Anti-inflammatory and pain, Ophthalmology, Anti-infectives, Urology, Respiratory, Blood disorders, and Oncology.

Contact Information

Website
www.zentiva.com
Formerly Known As
Leciva
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Former Stock Listing
1SKF401E
Corporate Office
  • U kabelovny 529/16
  • Dolní Měcholupy
  • Prague, 102 00
  • Czech Republic
+420 267 000 000

Zentiva Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zentiva Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zentiva‘s full profile, request access.

Request a free trial

Zentiva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25
Drug Discovery
Prague, Czech Republic
4,800 As of 2023
00.000
000000000 00 00.000

000000

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 000000000
New York, NY
00 As of 0000
00.00
000000 - 000 00.00

00000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
000000000000000
Rahway, NJ
00000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zentiva Competitors (82)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Anavex Life Sciences Corporation New York, NY 00 00.00 000000 - 000 00.00
Merck & Co. Corporation Rahway, NJ 00000 000.00 000000000 000.00
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA 000 00000 000000&0 00000
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA 0000 00.000 0000 00.000
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
You’re viewing 5 of 82 competitors. Get the full list »

Zentiva Patents

Zentiva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202317232-D0 Pharmaceutical compositions comprising amorphous solid solutions of rivaroxaban and copovidone and preparation methods thereof Pending 10-Nov-2023
GB-202312111-D0 Sitagliptin pharmaceutical composition with reduced amount of n-nitrosamine impurities Pending 08-Aug-2023
GB-202301853-D0 Method of reducing the amount of n-nitrosamine impurities Inactive 09-Feb-2023
GB-202207690-D0 Liquid pharmaceutical formulation of bisoprolol Inactive 25-May-2022 00000000
EP-4344698-A1 Liquid pharmaceutical formulation of bisoprolol Pending 25-May-2022 A61K9/08 0
To view Zentiva’s complete patent history, request access »

Zentiva Executive Team (14)

Name Title Board Seat Contact Info
Steffen Saltofte Chief Executive Officer
Kenneth Lynard Chief Financial Officer
Anant Atal Chief Strategy, Transformation & Corporate Development Officer
Cinzia Falasco Volpin General Manager, Italy
Martin Albert Chief Scientific Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Zentiva Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zentiva Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zentiva‘s full profile, request access.

Request a free trial

Zentiva Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sanofi (Zerinol and Schoum Solution) 06-Dec-2022 0000000000 Pharmaceuticals
Manufacturing Plant (Sanofi India) 29-May-2020 0000000000 000.00 Buildings and Property 0000 0000
Labormed Alvogen 07-Apr-2020 0000000000 Pharmaceuticals 0000 0000
Solacium Pharma 31-May-2019 0000000000 Pharmaceuticals 0000 0000
Creo Pharma 01-Apr-2019 Buyout/LBO Medical Supplies 0000 0000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Zentiva Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Saneca Pharmaceuticals 11-Aug-2003 0000000000 Completed
  • 2 buyers
To view Zentiva’s complete exits history, request access »

Zentiva FAQs

  • When was Zentiva founded?

    Zentiva was founded in 1993.

  • Who is the CEO of Zentiva?

    Steffen Saltofte is the CEO of Zentiva.

  • Where is Zentiva headquartered?

    Zentiva is headquartered in Prague, Czech Republic.

  • What is the size of Zentiva?

    Zentiva has 4,800 total employees.

  • What industry is Zentiva in?

    Zentiva’s primary industry is Drug Discovery.

  • Is Zentiva a private or public company?

    Zentiva is a Private company.

  • What is Zentiva’s current revenue?

    The current revenue for Zentiva is 00000.

  • How much funding has Zentiva raised over time?

    Zentiva has raised $2.09B.

  • Who are Zentiva’s investors?

    Advent International has invested in Zentiva.

  • Who are Zentiva’s competitors?

    Anavex Life Sciences, Merck & Co., Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, and Genentech are some of the 82 competitors of Zentiva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »